Hazlett, Burt & Watson’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$573K Hold
2,151
0.18% 132
2025
Q4
$538K Hold
2,151
0.17% 128
2025
Q3
$619K Hold
2,151
0.22% 106
2025
Q2
$564K Hold
2,151
0.23% 100
2025
Q1
$501K Hold
2,151
0.23% 103
2024
Q4
$494K Hold
2,151
0.22% 101
2024
Q3
$481K Hold
2,151
0.22% 105
2024
Q2
$439K Sell
2,151
-85
-4% -$17.3K 0.23% 98
2024
Q1
$488K Hold
2,236
0.29% 67
2023
Q4
$507K Hold
2,236
0.34% 63
2023
Q3
$449K Sell
2,236
-367
-14% -$77.4K 0.33% 61
2023
Q2
$539K Sell
2,603
-46
-2% -$8.92K 0.4% 47
2023
Q1
$523K Hold
2,649
0.43% 44
2022
Q4
$536K Hold
2,649
0.47% 43
2022
Q3
$466K Hold
2,649
0.45% 41
2022
Q2
$532K Hold
2,649
0.49% 42
2022
Q1
$599K Buy
+2,649
New +$623K 0.47% 44

Other funds holding LH

Hazlett, Burt & Watson's LH Position: Q1 2026 in Review

Hazlett, Burt & Watson held its Labcorp (LH) position steady in Q1 2026 at 2,151 shares worth $573K. The position accounts for 0.18% of the portfolio, ranked #132.

Hazlett, Burt & Watson first reported a position in LH in Q1 2022 and has held it in 17 quarters since. The position peaked at $619K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Hazlett, Burt & Watson held 2,151 shares of Labcorp worth $573K as of Q1 2026.
  • Hazlett, Burt & Watson left its Labcorp share count unchanged in Q1 2026.
  • Labcorp made up 0.18% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #132 holding.
  • Hazlett, Burt & Watson first reported a position in Labcorp in Q1 2022 and has held it in 17 quarters since.
  • Hazlett, Burt & Watson's Labcorp position peaked at $619K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.